About 2-7% of stage III or IV NSCLC patients and, more frequently, younger individuals, never or light smokers, which are more likely to develop brain metastases, have been shown to contain oncogenic fusion genes, including EML4 and ALK [71, 72]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.